Stocks and Investing
Stocks and Investing
Thu, September 17, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, September 16, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, September 15, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Geoffrey Porges Maintained (BIIB) at Buy with Decreased Target to $425 on, Sep 15th, 2015
Geoffrey Porges of Leerink Swann, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $464 to $425 on, Sep 15th, 2015.
Geoffrey has made no other calls on BIIB in the last 4 months.
There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Geoffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Skorney of "Baird" Downgraded from Buy to Hold and Decreased Target to $316 on, Monday, July 27th, 2015
- Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $410 on, Wednesday, July 22nd, 2015
These are the ratings of the 3 analyists that currently disagree with Geoffrey
- Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $380 on, Tuesday, August 11th, 2015
- Aaron Gal of "Bernstein" Upgraded from Hold to Buy and Decreased Target to $385 on, Monday, July 27th, 2015
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $426 on, Monday, July 27th, 2015